Ginsenoside Rd Inhibited Ferroptosis to Alleviate CCl-Induced Acute Liver Injury in Mice Via CGAS/STING Pathway
Overview
Authors
Affiliations
Carbon tetrachloride (CCl)-induced lipid peroxidation associated with hepatic oxidative stress and cell death is an important mechanism of acute liver injury (ALI). Ginsenoside Rd is considered an active ingredient of ginseng. Evidence suggests that ginsenoside Rd may improve ischaemic stroke, nerve damage, cancer and other diseases involving apoptosis, inflammation, oxidative stress, mitochondrial injury and autophagy. However, the effects of ginsenoside Rd on CCl-induced ALI and its underlying mechanisms are still unclear. In this study, 0.25% CCl was injected intraperitoneally in mice to establish a CCl-induced ALI model. In the Rd treatment group, Rd (10, 20[Formula: see text]mg/kg) doses were injected intraperitoneally 1[Formula: see text]h before and 23[Formula: see text]h after CCl administration. Ferroptosis inducer imidazole ketone erastin (IKE) was injected intraperitoneally 4[Formula: see text]h before CCl administration to explore the mechanism. The blood and liver were collected 24[Formula: see text]h after CCl administration to investigate the effect and mechanism of ginsenoside Rd on CCl-induced ALI. Our results showed that ginsenoside Rd inhibited CCl-induced ALI in mice. Ginsenoside Rd also downregulated CCl-induced serum and liver iron, 4-hydroxynonenal, and 8-hydroxy-2 deoxyguanosine levels. Furthermore, it upregulated glutathione and glutathione peroxidase 4 levels. In addition, ginsenoside Rd downregulated the expression of cGAS and STING. Subsequently, the ferroptosis inducer imidazole ketone erastin significantly reversed the hepatoprotective effect and influence of ginsenoside Rd with regard to the indicators mentioned above. Our study confirmed that ginsenoside Rd ameliorated CCl-induced ALI in mice, which was related to the reduction of ferroptosis. Simultaneously, the ginsenoside Rd-mediated inhibition of the cGAS/STING pathway contributed to its antiferroptosis effect. In conclusion, our results suggested that ginsenoside Rd inhibited ferroptosis via the cGAS/STING pathway, thereby protecting mice from CCl-induced ALI. These results suggested ginsenoside Rd may be used as a potential intervention treatment against CCl-induced ALI.
Liver diseases: epidemiology, causes, trends and predictions.
Gan C, Yuan Y, Shen H, Gao J, Kong X, Che Z Signal Transduct Target Ther. 2025; 10(1):33.
PMID: 39904973 PMC: 11794951. DOI: 10.1038/s41392-024-02072-z.
Zhong X, Sun Y, Lin Y, Deng S, Wang H, Zhou X Sci Rep. 2025; 15(1):3569.
PMID: 39875579 PMC: 11775168. DOI: 10.1038/s41598-025-87991-9.
Zhi H, Fu H, Zhang Y, Fan N, Zhao C, Li Y Front Immunol. 2024; 15:1510628.
PMID: 39737190 PMC: 11683013. DOI: 10.3389/fimmu.2024.1510628.
The cGAS-STING pathway and female reproductive system diseases.
Li R, Liu H, Liu Y Front Immunol. 2024; 15:1447719.
PMID: 39445027 PMC: 11496054. DOI: 10.3389/fimmu.2024.1447719.
The crucial roles and research advances of cGAS‑STING pathway in liver diseases.
Zhang X, He B, Lu J, Bao Q, Wang J, Yang Y Ann Med. 2024; 56(1):2394588.
PMID: 39183465 PMC: 11348815. DOI: 10.1080/07853890.2024.2394588.